首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿仑膦酸钠治疗绝经后妇女骨质疏松症1年临床疗效观察
引用本文:蔡飞龙.阿仑膦酸钠治疗绝经后妇女骨质疏松症1年临床疗效观察[J].海峡药学,2010,22(5):102-104.
作者姓名:蔡飞龙
作者单位:浙江省绍兴县中心医院骨科,绍兴,312030
摘    要:目的观察阿仑膦酸钠对绝经后妇女骨质疏松症的治疗作用。方法口服阿仑膦酸钠,70 mg每周1次,连用1年,分别在6个月和12个月观察骨密度、U-Ca、U-Cr和U-Ca/U-Cr。结果治疗后6个月和12个月,腰椎L2-4、股骨颈、大转子和全髋骨密度较治疗前都有显著提高(P〈0.05),治疗12个月后与治疗6个月后比较差异也有统计学意义(P〈0.05);治疗6个月后和治疗12个月后U-Ca和U-Ca/U-Cr较治疗前都有显著降低(P〈0.05),且治疗12个月后U-Ca和U-Ca/U-Cr与治疗6个月后比较差异也有统计学意义(P〈0.05);而U-Cr治疗前后差异则无统计学意义(P〉0.05)。结论阿仑膦酸钠对绝经后妇女骨质疏松症有很好的治疗作用。

关 键 词:阿仑膦酸钠  绝经  骨质疏松症  骨密度  空腹尿钙  尿肌酐

The efficacy of 1 year alendronate therapy in postmenopausal women with osteoporosis
CAI Fei-long.The efficacy of 1 year alendronate therapy in postmenopausal women with osteoporosis[J].Strait Pharmaceutical Journal,2010,22(5):102-104.
Authors:CAI Fei-long
Institution:CAI Fei-long(Zhejiang province shaoxing center Hospital orthopaedist shaoxing 312030,China)
Abstract:OBJECTIVE To observe the effect of alendronate on osteoporosis of postmenop-ausal women.METHODS The women chosen were given 70 mg per week alendmnate for 1 year,and then observed the BMD,U-Ca,U-Cr and U-Ca/U-Cr.RESULTS 1 year alenclrormte therapy produced a significant increase in BMD at the lumbar spine,femoral neck,trochanter and total hip(P〈0.05),and it was the same 6 months after treatment.The values of U-Ca and U-Ca/U-Cr at the basehne,6 months,and 12 months after taking alendronate were statistical significance(P〈0.05),but the U-Cr were statistically simitar(P〉0.05).CONCLUSION Alendronate was effective and safe in postmenopausal women with ostooporosis.
Keywords:Alendronate  Postmenopausal  Osteoporosis  BMD  U-Ca  U-Cr
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号